Normolax

Quick links to important sections

Normolax

Method of action: Laxative

Treatment option: Constipation, Proctitis

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Normolax

Normolax is a pharmaceutical preparation that serves as a stimulant laxative medication, actively promoting bowel evacuation. Its composition is defined by the sole, synthetic active ingredient, Sodium Picosulfate (INN), which is administered via the oral route. Normolax is recognized for its versatility, with the oral solution often utilized for flexible dosing.

What Type of Laxative is Normolax?

Normolax is specifically classified as a contact laxative or stimulant laxative, a type of cathartic agent that encourages movement within the large intestine. This classification describes its function as a medicine that directly interacts with the intestinal lining. This differentiates it from osmotic or bulk-forming agents that rely on passive water modification or volume increase. This mechanism allows the medicine to act on the intestine to facilitate elimination.

Composition and Available Forms of Normolax

The medicine is a single-agent product for oral administration, containing Sodium Picosulfate as its active substance. It is manufactured synthetically and commonly supplied as an oral solution (drops) and in tablet form. Functionally, Sodium Picosulfate operates as a prodrug; it is chemically inert upon ingestion and is converted by colonic bacteria to its active metabolite once it reaches the large bowel. This feature ensures the action is targeted and occurs once the substance reaches the appropriate segment of the intestine.

General Purpose of the Stimulant Laxative

The general therapeutic purpose of Normolax is to provide relief by accelerating and facilitating the process of stool elimination in cases of acute or occasional constipation. The stimulant action promotes muscle contractions and influences water dynamics in the colon, providing a mechanism to aid the body's natural function of waste removal. It is used for short-term assistance with bowel movement, such as when regular elimination patterns have been temporarily disrupted. In essence, the drug is designed to offer aid when the body requires assistance resuming normal waste elimination.

Regulatory References

  1. Sodium Picosulfate Mechanism of Action (NIH NLM)

What side effects are possible with Normolax?

Possible Side Effects and Safety Information

Normolax is generally well-tolerated when used according to regulatory instructions. However, it is essential to be aware of both common and serious documented adverse reactions.

Common Adverse Reactions

Common side effects primarily involve the gastrointestinal system and may include abdominal pain or cramping, diarrhea, nausea, bloating, and vomiting. Diarrhea, if persistent or severe, may lead to dehydration and may require a dosage reduction or temporary interruption of use.

Serious Adverse Reactions and Safety Restrictions

Serious harm is considered rare but is primarily associated with exceeding the recommended dose or using the product for longer than advised. Overuse can cause severe dehydration and dangerous abnormalities in serum electrolyte levels (e.g., sodium and potassium). These imbalances have the potential to lead to acute kidney injury, arrhythmias (irregular heart rhythm), and in very rare cases, death.

System-Organ Class Serious Adverse Reaction (Associated with Overuse)
Cardiovascular Arrhythmias (irregular heart rhythm)
Renal/Metabolic Acute kidney injury, severe dehydration, and electrolyte disturbances

Population-Specific Safety Considerations

Certain populations carry a higher risk for serious complications. Individuals with pre-existing conditions such as kidney disease, known or suspected bowel obstruction, severe acute colitis, or inflammatory bowel disease should not use this medication without professional consultation. Caution is also warranted for older adults and patients taking medications that may affect kidney function, such as diuretics or NSAIDs. Children aged five years and younger should only be given oral products under the direction of a healthcare professional.

Adhering strictly to the single-dose limit within a 24-hour period is the principal safety restriction to prevent serious, dose-related harm.

Overdose and Emergency Response

Normolax Overdose and When to Seek Help

Overdose of Sodium Picosulfate is officially documented to present with manifestations related to excessive stimulant laxative effects.

Documented Clinical Manifestations:

  • Acute Overdose: Diarrhoea, severe abdominal cramps, and clinically significant loss of potassium and other electrolytes.
  • Chronic Overdose/Abuse: Persistent abdominal pain, hypokalaemia (low potassium), secondary hyperaldosteronism, metabolic alkalosis, and muscle weakness.

Severe Outcomes and Emergency Intervention: High-dose exposure is associated with the risk of colonic mucosal ischaemia. Chronic abuse carries the risk of serious complications, including renal tubular damage, cardiac arrhythmias, and seizures resulting from severe electrolyte disturbances.

Immediate medical attention is required for any suspected overdose. Official regulatory guidance states that the user must contact a poison control center or emergency room at once.

Management and Supportive Care: Management is symptomatic and supportive; no specific antidote is known or listed in regulatory documentation. Treatment focuses on minimizing further absorption (e.g., gastric lavage for recent ingestion) and mandatory procedures: the replacement of fluids and the correction of electrolyte imbalance. This replacement is noted as especially important in the elderly and the young due to heightened vulnerability to fluid loss.

Therapeutic Uses of Normolax

What Normolax Treats: Main Uses and Benefits

Normolax is commonly used to help with acute or occasional constipation, which is generally characterized by infrequent bowel movements and symptoms associated with acute or episodic changes. This therapeutic support may be part of symptomatic management to help ease discomfort and may assist with the elimination process. The medication is considered relevant for managing constipation and assists with maintaining functional stability.

The medication is applied in addressing symptoms related to physical discomfort, particularly when symptoms involve hard, dry stools. This may assist with the reduction of painful straining and associated abdominal discomfort, supporting the patient during difficult episodes by easing distress. The therapeutic scope is relevant for conditions presenting with acute episodes of constipation, and for use in clinical contexts requiring additional symptomatic assistance, such as bowel preparation.

The medication is considered relevant in clinical settings that involve acute or unstable symptom patterns where supportive symptom management is appropriate. This is commonly used when the therapeutic scope includes temporary colon cleansing prior to diagnostic or surgical procedures, and provides necessary support to patient groups, such as those with piles or certain cardiovascular disorders, where symptoms that create noticeable physiological strain must be managed.

“This symptomatic relief may assist with the reduction of physical discomfort during difficult elimination, contributing to improved day-to-day comfort.”


Quick Fact: Relevant for Managing Symptoms of Straining, Hard Stools, and Infrequent Bowel Movements


Regulatory References

  1. European Regulatory Documentation on Sodium Picosulfate

Eligibility and Restrictions for Use

Eligibility for Normolax (Sodium Picosulfate)

The medicine's eligibility is strictly defined by regulatory documents, distinguishing between permitted use, use requiring caution, and absolute contraindications. Normolax is primarily established for use in adults.

Age-Group Rules Status
Adults Established use.
Pediatric Patients Approved for children 9 years of age and older (U.S. labeling) or 10 years and older (European labeling).
Children under 9/10 years Use is generally not recommended or not established for the respective indications.

Contraindicated Populations

The medicine is strictly contraindicated and must not be used in patients with certain acute gastrointestinal conditions, including: gastrointestinal obstruction or ileus, bowel perforation, toxic megacolon, acute appendicitis, acute inflammatory bowel disease, or gastric retention. Use is also prohibited in cases of severe dehydration and acute hepatic failure. Patients with severe renal impairment (creatinine clearance less than 30 mL/minute) are contraindicated when using combination formulations.

Restricted and Conditional Use

Use requires caution in patients with pre-existing heart disease or a history of recent gastrointestinal surgery. For pregnancy, use is not recommended unless the expected benefit outweighs potential risks. For lactation, the active substance's metabolite is minimally transferred, and use is generally considered acceptable, though caution is still advised.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction scope

Medicinal product categories with documented interactions: Diuretics, Corticosteroids, Other Laxatives/Cathartic Agents, Cardiac Glycosides, and Medications that Lower the Seizure Threshold (e.g., Tricyclic Antidepressants, certain Antipsychotics).

Specific interacting medicines (if explicitly listed): Digoxin, Tetracycline and Fluoroquinolone Antibiotics, Iron supplements, Chlorpromazine, and Penicillamine.

Mechanistic basis of interactions (only if stated in label): Pharmacodynamic interactions involving fluid and electrolyte abnormalities; reduction of efficacy due to interference with colonic bacterial conversion of the prodrug; and reduced absorption of co-administered drugs due to accelerated gastrointestinal transit.

Timing-based interaction rules (if applicable): Do not take oral medications within one hour of the start of administration. Specific drugs, including Digoxin and certain Antibiotics, must be administered at least 2 hours before and not less than 6 hours after administration.

Interaction-related restrictions: Alcohol is restricted, and the consumption of solid food or milk must be avoided during the treatment period.

Population-specific interaction notes (if applicable): Use is contraindicated in patients with severe renal impairment (creatinine clearance less than 30 mL/min), primarily due to the risk of magnesium accumulation.

Official interaction statements:

  • Co-administration with Diuretics or Corticosteroids increases the risk of fluid and electrolyte abnormalities, particularly hypokalemia.
  • Electrolyte disturbances may increase the risk of Digoxin toxicity by sensitizing the heart muscle.
  • Prior or concomitant use of Antibiotics may reduce the efficacy of Normolax by altering the gut bacteria required for the prodrug conversion.

Connection to the overall interaction profile (2–4 sentences): The regulatory documents define the product's interaction structure by highlighting the potential for pharmacodynamic synergy leading to electrolyte imbalance and the risk of reduced exposure for both the laxative and other oral drugs. These regulatory statements establish mandatory timing separation for specific medications to mitigate the risks associated with rapid gastrointestinal transit and microbial interference.

Mechanism of Action

Activation by Colonic Bacteria

The core of the mechanism involves a mandatory conversion step: the synthetic molecule, Sodium Picosulfate, is chemically inactive until it reaches the large intestine. Here, specialized bacterial enzymes (hydrolases and sulfatases) cleave the molecule, releasing the biologically active metabolite, BHPM (Bis-(p-hydroxy-phenyl)-pyridyl-2-methane). This conversion process localizes the drug's activity, restricting the action to the target tissue of the colon.


Dual Stimulation of Motility and Fluid Transport

Once released, the active metabolite BHPM exerts a dual physiological influence on the large intestine. It functions as a contact stimulant by directly activating the sensory nerve endings of the Enteric Nervous System (ENS) within the colon wall, thereby triggering and enhancing propulsive muscle contractions (peristalsis). Simultaneously, BHPM modulates epithelial cells to inhibit water and electrolyte absorption while increasing fluid secretion into the lumen. The resulting physiological consequence is a combination of accelerated transit and increased stool volume/hydration, which aids the process of bowel movement.


Constraints on the Mechanism

The mechanism is constrained by its reliance on the colonic microflora for conversion; conditions that diminish the necessary bacterial population, such as the use of broad-spectrum antibiotics, may reduce or delay the conversion of the prodrug. The mechanism is strictly peripheral, localized to the large intestine, and is dependent on gastrointestinal transit time for the prodrug to reach the site of conversion.

Dosage and Administration Information

The administration of Normolax, which contains Sodium Picosulfate, is strictly by the oral route across all authorized formulations, including tablets, liquid solution, and powder for oral reconstitution.

Labeled Dosing and Frequency

The standard regimen for occasional constipation specifies a dose range for adults, typically starting at 5 mg and not exceeding 10 mg in a 24-hour period. Dosage adjustments are made based on individual response, with the goal of finding the minimum effective amount. This medicine is administered once daily, with the official scheduling recommendation being at bedtime. This timing is based on the compound's predictable onset of action, which commonly occurs 6 to 12 hours after ingestion.

For its use as part of bowel cleansing preparations before a procedure, the medicine is used in combination with other agents. The standard regimen requires the oral administration of two separate doses of 10 mg of sodium picosulfate, following either a split-dose or day-before schedule.

Duration and Administration Context

The use of Normolax for constipation relief is officially restricted to short-term courses and should not generally exceed five consecutive days without further medical review. When using the liquid or tablet forms, adequate fluid intake is a required component of the administration protocol. Specific preparation is necessary for the powder form: it must be reconstituted with cold water immediately before use and not prepared in advance. The official age-specific use rule notes that pediatric patients 10 years and older typically follow the adult dosage range.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Normolax

Evidence for Use in Occasional and Chronic Constipation

Research has explored how Sodium Picosulfate was evaluated in adults experiencing constipation that is either occasional or chronic. Research primarily relies on short-term Randomized Controlled Trials (RCTs) and systematic reviews that examined comparisons against an inactive placebo or other treatments. The studies examined outcomes reflecting daily functioning, specifically monitoring changes in stool frequency and stool consistency using standardized measurements. Researchers also monitored patient-reported outcomes describing perceived discomfort, such as straining and overall quality of life related to bowel movements.

Trials described patterns observed in the measured outcomes, with data showing patterns related to average stool frequency and stool consistency in the group receiving Sodium Picosulfate. The studies reported measurements of symptom variables. The results apply only to the populations studied. Findings describe group patterns, not personal outcomes, and reflect the specific conditions under which the trials were conducted during periods of increased symptom activity.

Evidence for Use in Bowel Cleansing Procedures

Extensive research, primarily composed of large-scale RCTs and comparative meta-analyses, explored the use of Sodium Picosulfate in a combination product (often with magnesium citrate) for bowel cleansing prior to diagnostic procedures like colonoscopy. The main outcome monitored was the level of bowel cleansing, using objective, validated rating scales. Trials also examined outcomes related to physical discomfort, such as patient compliance with the regimen and patient acceptance.

Studies described patterns observed where measurements of bowel cleansing were observed in a defined percentage of patients. Findings indicating that the results may be similar to those of other preparation solutions. The evidence is limited to the use of the combination product, and this research primarily focuses on outpatients preparing for an elective procedure.

Evaluation of Long-Term Studies and Follow-up Duration

When researchers explored short-term symptom changes for occasional constipation relief, the follow-up durations were limited. The vast majority of the research for this indication was observed in trials lasting between three days and up to four weeks. Long-term effects are not fully established regarding the continuous or sustained use of Normolax for managing chronic constipation. There is limited information for long-term outcomes that track effects over many months or years in formal controlled trials.

Research in Special Populations

The research has examined specific subgroups beyond the general adult population. For the purpose of bowel cleansing for procedures, studies were evaluated in some older adults (aged 66 years and over) as well as children and adolescents (typically 9 to 16 years old).

However, data for certain groups remain insufficient. For instance, the available evidence is limited in specialized populations like individuals with underlying renal impairment. Overall, the results apply only to the populations studied, and extrapolation to other specific clinical groups may be uncertain.

What is Still Uncertain in the Research Record

The current body of evidence highlights what is known — and what is still uncertain. The key limitations often cited in scientific reviews are that follow-up durations were limited for the chronic constipation indication, and long-term effects are not fully established. Comparative evidence is lacking regarding how Normolax was evaluated in relation to certain newer classes of laxatives in the context of long-term use. These research summaries provide context but not individual predictions about personal outcomes.

Key Studies & References

  1. Boehringer Ingelheim Risk Management Plan for Sodium Picosulfate (Laxoberal/Dulcolax)
  2. Health Products Regulatory Authority Public Assessment Report for a Medicinal Product (Sodium Picosulfate, Magnesium Oxide, and Citric Acid Combination)

Frequently Asked Questions (FAQ)

Common questions about Normolax (FAQ)


Q: How quickly does Normolax typically start to work after taking it?

According to official product information, the medicine is designed to have a delayed effect. The onset of its laxative action commonly occurs within a window of 6 to 12 hours after it is administered.


Q: Can Normolax be crushed or split?

Official guidance addresses the proper administration of the available forms, noting that the powder form requires immediate reconstitution. Official information does not contain data or instructions for crushing or splitting the tablets.


Q: What does 'contraindication' mean in relation to Normolax?

In regulatory documents, a 'contraindication' identifies a specific situation or condition in which the medicine must not be used because using it could result in harm. For Normolax, this includes conditions like acute inflammatory bowel disease, bowel obstruction, or severe dehydration.


Q: Does Normolax interact with common pain relievers?

Official documents advise that caution is warranted if the medicine is used alongside Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), a class of non-steroidal anti-inflammatory drugs. This caution is due to the potential for risks related to fluid and electrolyte disturbances when these medicines are combined.


Q: What is the typical time frame for side effects to appear after starting Normolax?

Since the medicine's stimulant action is delayed (typically 6 to 12 hours after administration), common gastrointestinal side effects, such as abdominal cramps and diarrhea, may occur during the hours following administration, consistent with the expected onset of effect.


Q: Is it okay to take Normolax on an empty stomach?

The regulatory documents note that this medicine is typically administered at bedtime. While adequate fluid intake is required, the label does not explicitly state that the medicine must be taken with or without food for occasional constipation, though specific protocols restrict solid food and milk.


Q: Does Normolax interact with caffeine?

Regulatory documents list specific restrictions on substances like alcohol, solid food, and milk. Caffeine is not listed as a specific interacting substance in the official regulatory documents for this medicine.


Q: Does Normolax affect blood pressure or heart rate?

Official warnings state that irregular heart rhythm (arrhythmias) is a possible serious effect associated with overuse and severe electrolyte imbalances. The regulatory information does not routinely include effects on blood pressure or heart rate when the medicine is used for occasional constipation.


Q: Are there any specific tests or checks needed before starting Normolax?

The regulatory guidance for occasional constipation does not typically require specific lab tests before starting the medicine. However, because the medicine is strictly contraindicated in certain conditions like severe dehydration, caution and professional assessment are advised for patients with pre-existing health concerns.


Q: What are the general expectations about the duration of the drug's effect?

The medicine is for short-term assistance, and its stimulant effect typically results in a bowel movement within 6 to 12 hours after administration. This timeframe indicates the general period during which the active effect is concentrated.


Q: Is Normolax considered a prescription drug or can you buy it without one?

Regulatory classification varies by country and formulation. In some countries, the medicine is available to buy without a prescription for short-term relief of occasional constipation. Specific regulatory requirements, such as age limits or pack sizes, may apply to over-the-counter use.


Q: Do you have to take Normolax every day?

No, the medicine is intended for short-term relief of occasional constipation. It is administered once daily, but it is not generally intended for continuous daily use exceeding a few days.


Q: What happens if you miss a time you were supposed to take Normolax?

Official patient guidance indicates that a missed dose should typically not be taken. The advice is to wait and take the next dose at the regularly scheduled time.


Q: Does Normolax work for everyone who takes it?

Clinical trials and official information describe patterns of effectiveness in the populations studied. However, regulatory documents do not guarantee effectiveness, as individual response may vary.


Q: Are there any specific foods or drinks that should be avoided when using Normolax?

Yes, official documents restrict the consumption of alcohol while using the medicine. Additionally, solid food and milk must be avoided during the specific treatment period when the medicine is used for bowel cleansing preparations.


Q: Is Normolax safe for older adults (seniors)?

Official information indicates that studies have not demonstrated problems specific to the geriatric population that would limit use. However, due to factors like pre-existing conditions and higher risk for fluid or electrolyte imbalances, caution is generally advised in the older adult population.


Q: Can people who have certain long-term health issues use Normolax?

The medicine is strictly contraindicated in patients with certain acute conditions, such as inflammatory bowel disease or bowel obstruction. Caution is generally advised for patients with pre-existing heart or kidney issues.


Q: How long can a person generally expect to use Normolax?

The medicine is officially restricted to short-term courses for occasional constipation. Official guidance states that use should generally not exceed five consecutive days unless the usage has been reviewed by a healthcare professional.


Q: What are the signs that Normolax might be starting to work?

As a stimulant laxative, the most common signs that the medicine is starting to work include the onset of abdominal discomfort or cramping. This is usually followed by an increased urge to pass stool, leading to loose stools or diarrhea.


Q: Are there studies looking at the long-term effects of using Normolax?

Official research summaries state that follow-up durations were limited in studies for constipation relief, typically lasting up to four weeks. Long-term effects have not been fully established regarding the continuous or sustained use of the medicine.


Q: Can a person stop using Normolax suddenly?

The medicine is generally for short-term use for occasional constipation. Official patient information suggests that for occasional constipation, use may be stopped when bowel regularity has been restored.


Q: Can taking too much Normolax cause serious issues?

Yes, official warnings state that serious harm is primarily associated with exceeding the recommended dose or using the product for longer than advised. Overuse can lead to severe dehydration and dangerous abnormalities in serum electrolyte levels (like potassium and sodium).


Q: Are there different strengths or versions of Normolax available?

The medicine is generally available in an oral solution (drops) and tablet forms for administration. This addresses the question of different versions or forms.


Q: Is Normolax used for temporary or ongoing issues?

The general purpose of the medicine is to provide effective relief for acute or occasional constipation. Its use is officially restricted to short-term courses, indicating it is intended for temporary assistance rather than ongoing, chronic issues.


Q: Does Normolax cause dependency or addiction?

Official warnings state that the overuse of stimulant laxatives must be avoided. Prolonged or excessive use can lead to the digestive system becoming dependent on stimulation and may result in worsened constipation.


Q: Are there warnings about driving or operating machinery while using Normolax?

Official information advises caution when driving or operating machinery. This is because isolated events of dizziness or fainting have been reported, and patients should not drive or operate machinery if they experience these effects.


Q: Can Normolax cause changes in mood or sleep?

Changes in mood or sleep are not listed among the common side effects in regulatory documents. However, serious effects associated with overuse, such as severe electrolyte imbalance, can potentially lead to neurological abnormalities.


Q: What should be done if a potential interaction is noticed?

Official documents strongly recommend that if a potential drug interaction is noticed or if you have any questions about combining medicines, consultation with a doctor or pharmacist is strongly recommended.


Q: Is there a maximum time Normolax can be used according to official sources?

Yes, official guidance for occasional constipation states that the medicine should not generally be used for longer than five consecutive days. This is the maximum duration for a short-term course without a medical review.


Q: Can Normolax be used by people who are physically active or athletes?

Regulatory documents do not restrict the medicine based on physical activity level. However, official warnings emphasize the risk of dehydration and electrolyte imbalance, which may be heightened during periods of intense physical activity, requiring careful hydration.


Q: Is it true that Normolax has minimal reported interactions?

Official regulatory documents list several medicinal product categories with documented interactions, including Diuretics, Corticosteroids, and Antibiotics. The labels also establish specific timing rules for administering certain medications to prevent interference.


Q: Does body weight influence how Normolax works?

Clinical research evidence for the combination product used in bowel cleansing suggests that body mass, including obesity, did not affect the quality of the bowel cleansing outcome when no dose modification was made.


Q: Why are people with certain pre-existing conditions advised against using Normolax?

The contraindications are based on the medicine's mechanism of action and composition. For example, use is prohibited in severe renal (kidney) impairment due to the risk of magnesium accumulation, and in bowel obstruction because the stimulant action could potentially worsen the blockage.


Q: Is a follow-up appointment necessary after starting Normolax?

Official guidance implies a need for follow-up review if the short-term use limit is exceeded. If the medicine is needed every day, regulatory guidance implies that a doctor should be consulted to find the cause of the constipation.


Q: What are the most common reasons people stop using Normolax?

Adverse reactions documents indicate that diarrhea, if persistent or severe, may require dosage reduction or temporary interruption of use. This suggests that severe diarrhea is a common reason for a patient to stop or interrupt treatment.


Q: What does the research say about Normolax in different ethnic groups?

While the general research overview does not focus on ethnic groups, specific clinical trials and meta-analyses published in authoritative databases have examined the medicine's use in various international populations.

How should Normolax be stored and disposed of?

How to Store and Dispose of Normolax?

Normolax (Sodium Picosulfate) must be stored and disposed of according to official regulatory labeling to ensure product stability and household safety.


Storage Requirements

The medication must be kept at Controlled Room Temperature, which is between 68 F and 77 F (20 C to 25 C). It must be stored in its original container with the cap tightly closed and protected from light, excessive heat, and moisture. It is required that the product not be frozen.


️ Disposal and Child Safety

Mandatory storage requires keeping Normolax out of the sight and reach of children.

Unused or expired medication must be disposed of properly. Do not flush Normolax down the toilet or pour it into a drain. Disposal should be done via a drug take-back program or by following specific household trash guidelines for unneeded medicines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Normolax found in:

A-Z Index: